Vaxcyte

Associate Scientist II, Analytical Development

Vaxcyte  •  $105k - $123k/yr  •  San Carlos, CA (Onsite)  •  4 days ago
Apply
Save Job
Mark Applied Mark Interviewed Mark Offered
Hide Job Report Job
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Join our Mission to Protect Humankind!

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.

Vaxcyte is looking for an energetic and talented individual to join our analytical development team. The primary responsibilities for the successful candidate will include method development, sample testing, analyzing data, and authorizing protocols and reports.

Essential Functions:

  • Assist in analytical method development of new assays.
  • Perform analytical testing, data analysis and present in team meetings.
  • Maintain thorough and accurate records of laboratory work.
  • Support daily lab operations, sample inventory and sample shipment.
  • Author analytical documents including but not limited to test method, protocols, and reports.

Requirements:

  • BS in Chemistry, Analytical Chemistry preferred, Organic / Biochemistry considered, with 2+ years of relevant industry experience, or MS with 1+ years of experience. Other combinations of education and/or experience may be considered.
  • Experience in chemical and biological assays such as colorimetric/ fluorometric microplate assays, PCR/qPCR, HPLC, CE, UV-Vis, ELISA and LC-MS.
  • Understanding of basic principles of analytical method development/ validation/ qualification concepts.
  • Attention to detail and excellent skills in record keeping/documentation.
  • Strong interpersonal skills and ability to communicate effectively both verbally and in written formats.
  • This position is a lab-based role and requires onsite presence.
Reports to: Senior Scientist, Analytical Development
Location: San Carlos, CA

Work Arrangement: Onsite (5 days per week)

Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Salary Range: $105,000 – $123,000

We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.

Vaxcyte

About Vaxcyte

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. We are developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

VAX-31, our 31-valent pneumococcal conjugate vaccine (PCV) candidate advancing to a Phase 3 adult clinical program and currently being evaluated in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) in adults and infants and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, our 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market and is currently being evaluated in a Phase 2 infant study. Both VAX-31 and VAX-24 are designed to improve upon the standard-of-care PCVs by covering the serotypes in circulation that are responsible for a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains that are currently contained through continued vaccination practice.

We are re-engineering the way highly complex vaccines are made. Unlike conventional cell-based approaches, our system for producing difficult-to-make proteins and antigens is intended to accelerate our ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits.

In addition to our PCV franchise, our pipeline includes early-stage programs targeting Group A Strep, periodontitis and Shigella. At Vaxcyte, we are driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
San Carlos, California
Year Founded
2013
Website
vaxcyte.com
Social Media